Biology subjects

Gutierrez, O.

Publications and source records attributed to Gutierrez, O..

3 recordsLinked to original sources

bioRxiv2026

Redox-dependent lipophilicity of phenazine metabolites is modulated by intramolecular hydrogen bonds and controls their biological distribution

Phenazines are redox-active microbial metabolites produced and secreted in diverse ecological contexts from soils to chronic infections. In these disparate environments phenazines can function variously as antibiotics, extracellular electron shuttles, and nutrient scavengers. Key to understanding the impact of these functions is a robust expectation of phenazine retention or diffusion in a given context. But predicting phenazine fate and transport is difficult because of the chemical complexity of their local microenvironments. To address this challenge, we measured the octanol water distribution coefficient (LogD) as a proxy for lipophilicity of three naturally occurring phenazines produced by the opportunistic pathogen Pseudomonas aeruginosa: phenazine-1-carboxylic acid, phenazine-1-carboxamide, and pyocyanin. We investigated the behavior of both oxidized and reduced forms of these phenazines across broad ionic strength and pH conditions. While the ionic context exerts only small effects, the pH and redox state contribute strongly and independently to changes in phenazine lipophilicity. The pH trends are expected, but the observed redox dependence is generally missed by existing lipophilicity calculation methods. Additional LogD measurements with 1-hydroxyphenazine and unsubstituted phenazine, together with density functional theory modeling of phenazines in their reduced and oxidized forms, reveal that intramolecular hydrogen bonding contributes significantly to the increased lipophilicity of reduced phenazines that possess H-bond accepting substituents in the 1-position. These results explain phenazine behavior in a biological context: redox state alone significantly alters retention of pyocyanin in planktonic P. aeruginosa cells, with the reduced species being predominantly retained by membranes. We propose that the modulation of phenazine lipophilicity in response to the local redox environment has evolved to give a competitive advantage to bacteria by retaining or dispersing these bioactive molecules. Beyond improving our understanding of natural phenazine fate in diverse microbial contexts, our results emphasize an oft-overlooked theme relevant to rational drug and electrochemical shuttle design: redox state matters.

biochemistry↗

bioRxiv2025

Nitric oxide tunes secreted metabolite bioactivity

The radical nitric oxide ({middle dot}NO) is short-lived but has imprinted itself on many aspects of physiology and disease. {middle dot}NOs rapid production and consumption, coupled with its intrinsic reactivity, drive its biological importance; thus, defining mechanisms and targets of {middle dot}NO reactivity is necessary to assess its fate and impact. Cellular small molecules are a major class of {middle dot}NO-reactive targets, possessing a variety of molecular functionalities that can react with {middle dot}NO. Yet the capacity for secreted small molecules to react with {middle dot}NO, as well as the biological consequences of such reactivity, have received little attention. Here, we explore the reactivity of {middle dot}NO with phenazine metabolites, microbially-derived secreted small molecules that possess antibiotic properties and can modulate their microenvironment. Using Pseudomonas aeruginosa as a model phenazine producer, we find that {middle dot}NO reacts with specific phenazines to yield stable, chemically-distinct products. These chemical transformations significantly attenuate phenazine antibiotic properties, including against the phenazine nonproducer Staphylococcus aureus, a competitor with P. aeruginosa for niches in the context of infection. By contrast, P. aeruginosa experiences rapid loss in viability when phenazines and {middle dot}NO react. This toxicity occurs even in the presence of S. aureus, which displays resistance to nitrosylated phenazines, implicating a specific toxicity dependent on the formation of the phenazine-NO adduct. These findings highlight the capacity of {middle dot}NO to transform metabolite activity and suggest that {middle dot}NO can tune microbial interactions in complex environments by a mechanism of action hitherto unappreciated.

microbiology↗

bioRxiv2021

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling

Elevations in plasma phosphate concentrations (hyperphosphatemia) occur in chronic kidney disease (CKD), in certain genetic disorders, and following the intake of a phosphate-rich diet. Whether hyperphosphatemia and/or associated changes in metabolic regulators, including elevations of fibroblast growth factor 23 (FGF23) directly contribute to specific complications of CKD is uncertain. Here we report that similar to patients with CKD, mice with adenine-induced CKD develop inflammation, anemia and skeletal muscle wasting. These complications are also observed in mice fed high phosphate diet even without CKD. Ablation of pathologic FGF23- FGFR4 signaling did not protect mice on an increased phosphate diet or mice with adenine- induced CKD from these sequelae. However, low phosphate diet ameliorated anemia and skeletal muscle wasting in a genetic mouse model of CKD. Our mechanistic in vitro studies indicate that phosphate elevations induce inflammatory signaling and increase hepcidin expression in hepatocytes, a potential causative link between hyperphosphatemia, anemia and skeletal muscle dysfunction. Our study suggests that high phosphate intake, as caused by the consumption of processed food, may have harmful effects irrespective of pre-existing kidney injury, supporting not only the clinical utility of treating hyperphosphatemia in CKD patients but also arguing for limiting phosphate intake in healthy individuals.

cell biology↗